Literature DB >> 23532437

A case of natalizumab-associated progressive multifocal leukoencephalopathy-role for advanced MRI?

M Berghoff1, B Dassinger, J Iwinska-Zelder, M Giraldo, S Bilgin, M Kaps, E R Gizewski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23532437     DOI： 10.1007/s00062-013-0216-z

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN： 1869-1439            Impact factor:   3.649


× No keyword cloud information.
  5 in total

1.  Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome.

Authors:  P M Matthews; D Tampieri; S F Berkovic; F Andermann; K Silver; D Chityat; D L Arnold
Journal:  Neurology       Date:  1991-07       Impact factor: 9.910

2.  Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis.

Authors:  Alexandra Schröder; De-Hyung Lee; Kerstin Hellwig; Carsten Lukas; Ralf A Linker; Ralf Gold
Journal:  Arch Neurol       Date:  2010-07-12

Review 3.  Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis.

Authors:  M A Sahraian; E-W Radue; A Eshaghi; S Besliu; A Minagar
Journal:  Eur J Neurol       Date:  2011-12-05       Impact factor: 6.089

Review 4.  MR spectroscopy in multiple sclerosis.

Authors:  Nicola De Stefano; Massimo Filippi
Journal:  J Neuroimaging       Date:  2007-04       Impact factor: 2.486

5.  Treatment of progressive multifocal leukoencephalopathy associated with natalizumab.

Authors:  Werner Wenning; Aiden Haghikia; Jörg Laubenberger; David B Clifford; Peter F Behrens; Andrew Chan; Ralf Gold
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245
  5 in total
  3 in total

1.  Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.

Authors:  Roderick P P W M Maas; Annemarie H G Muller-Hansma; Rianne A J Esselink; Jean-Luc Murk; Clemens Warnke; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

2.  Insight into Metabolic 1H-MRS Changes in Natalizumab Induced Progressive Multifocal Leukoencephalopathy Brain Lesions.

Authors:  Ruth Schneider; Barbara Bellenberg; Robert Hoepner; Gisa Ellrichmann; Ralf Gold; Carsten Lukas
Journal:  Front Neurol       Date:  2017-09-05       Impact factor: 4.003

3.  Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).

Authors:  Ruth Schneider; Barbara Bellenberg; Robert Hoepner; Eva-Maria Kolb; Gisa Ellrichmann; Aiden Haghikia; Ralf Gold; Carsten Lukas
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.